Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes

Figure 1

SALL4 expression was increased in MDS patients and correlated with disease progression and treatment status. (A) SALL4 expression levels by microarray in 206 MDS cohort (GSE13159). The data was presented as log-transformed scaled signal (DS signal). (B) SALL4 expression in the healthy control, MDS, MDS-AML, MDS-post treatment and THP-1 positive control analyzed by qRT-PCR. * P-value<0.05, ***p-value<0.001. The lines indicate mean value of each group.

Back to article page